Skip to main content
Clinical Trials/IRCT201112143320N6
IRCT201112143320N6Completed未知

Effect of probiotic containing lactobacillus, bifidobacterium and streptococus thermophilus administration on inflammatory, coagulation and oxidative factors in critically ill patients with risk of sepsis

Tabriz University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 40 years (—)
Sex
All

Inclusion Criteria

  • 1) critically ill patients admitted to the surgical ICU with positive SIRS and APACHE II score 15 to 30; 2) receiving enteral nutrition; 3) aging 18-40 years old; 4) expected to stay in ICU for at least 7 days. Exclusion criteria: 1) pregnant and lactating women; 2) patients who cannot tolerate enteral nutrition; 3) unstable hemodynamic; 4) smoking; 5) immune disorders and diabetes mellitus; 6) intestinal obstruction; 7) intestinal ischemia; 8) Patients who are expected to expire in the next 24 hours; 9) HIV-positive; 10) cancer; 11) bedsore; 12) bone marrow, liver or lung transplantation; 13) short bowel syndrome, pancreatitis and kidney or liver failure; 14) receiving Lactulose, mannitol, and glutamine during the study; 15) patients undergoing GI procedures (endoscopy, resection of the bowel and GI surgeries) during the study.

Exclusion Criteria

  • Not provided

Investigators

Similar Trials

Effect of probiotic on management of... | Clinical Trial